Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Diagnostic performance of comprehensive point-of-Care ultrasound for pediatric tuberculosis in Spain: A prospective observational study

  • Munyangaju, Isabelle
  • Noguera Julian, Antoni
  • Soler-García, Aleix
  • Soriano-Arandes, Antoni
  • Escudero Fernández, José Miguel
  • Espiau, María
  • Santiago Garcia, Begoña
  • Hernanz-Lobo, Alicia
  • Lancharro Zapata, Ángel M.
  • Ladera, Enrique
  • Manzanares, Angela
  • Blazquez, Daniel
  • Aguirre Pascual, Elisa
  • Thierry-Chef, Isabelle
  • Buonsenso, Danilo
  • Serres-Créixams, Xavier
  • Bassat, Quique
  • Lopez-Varela, Elisa
Background: Diagnosing tuberculosis (TB) in children is challenging because of nonspecific symptoms, low microbiological yield, and imaging limitations. Comprehensive point-of-care ultrasound (cPOCUS) may detect mediastinal lymphadenopathy, but evidence remains limited. Methods: We conducted a prospective observational study in four tertiary hospitals in Spain (May 2023-June 2024) enrolling children (0-18 years) with presumptive TB. All participants underwent chest X-ray (CXR) and cPOCUS; chest CT was performed when clinically indicated. cPOCUS assessed lung, mediastinal, and abdominal compartments using a standardized protocol. Images were independently reviewed by expert readers blinded to clinical data. Diagnostic performance was evaluated against a final TB classification based on clinical, immunological, microbiological, and conventional radiological findings, excluding cPOCUS. Results: Twenty-seven children were included (median age 9.0 years), of whom 12 (44.4%) had TB disease. CT was performed in 14 (51.9%). Only 22.2% of cPOCUS examinations were complete. Mediastinal lymphadenopathy was the most frequent abnormality. cPOCUS detected abnormalities in 58.3%-63.6% of TB cases, particularly aortopulmonary window lymph nodes and small subpleural consolidations, with moderate sensitivity and high specificity (80.0%-86.7%). Inter-reader agreement was high (¿ = 0.92). Conclusions: In this pilot prospective study, cPOCUS demonstrated limited diagnostic performance but high inter-reader reliability. These exploratory findings suggest that cPOCUS may complement standard imaging for selected abnormalities (particularly aortopulmonary window lymphadenopathy), but larger studies with optimized protocols are needed before broader clinical implementation., I.M., Q.B., E.L.-V., and I.T.-C. acknowledge the support from the grant CEX2018-000806-S funded by MCIN/AEI (Ministerio de Ciencia e Innovación)/10.13039/501100011033. I.M. acknowledges the support of a fellowship from the `La Caixa¿ Foundation (ID 100010434). The fellowship code is LCF/BQ/DI21/11860045. E.L.-V. acknowledges the support from European Respiratory Society and the European Union's H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 847462 and Beca de Investigación INVEST-AEP 2022. Grants to A.N.-J.: Carlos III Institute of Health, Ministry of Economy and Competitiveness of Spain (grant no. PI22/00766); and Spanish Society of Pneumology and Thoracic Surgery (grant no. 169-2022). None of the funding sources had a role in the study's design, conduct and reporting. All other authors received no specific funding for this work. There was no additional external funding received for this study.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance

  • Laborda, Pablo
  • Lolle, Signe
  • Hernando-Amado, Sara
  • Alcalde-Rico, Manuel
  • Aanæs, Kasper
  • Martínez, José Luis
  • Molin, Søren
  • Krogh Johansen, Helle
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/., Mutations in mexZ, encoding a negative regulator of the expression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests., We thank Professor Ronald G. Cristal (Weil Cornell Medical College, New York, USA) for the Basal Cell Immortalized Non-Smoker 1.1 (BCi-NS1.1) cell line and Professor Víctor de Lorenzo (Centro Nacional de Biotecnología, CSIC, Madrid, Spain) for the donation of the pSEVA234 plasmid. P.L. was the recipient of an European Molecular Biology Organization (EMBO) Scientific Exchange Grant (Ref. nr: 9112) and afterwards a of an ERS/EU RESPIRE4 Marie Skłodowska-Curie Postdoctoral Research Fellowship (Ref. nr: R4202305-01047; this project has received funding from the European Respiratory Society and the European Union’s H2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 847462). Work in J.L.M. laboratory was supported by the Ministerio de Ciencia e Innovación/Agencia Estatal de Investigación (MCIN/AEI) 10.13039/501100011033 through grant PID2020-113521RB-I00. The work was further supported by a Novo Nordisk Foundation Challenge grant NNF19OC0056411 and a grant from THE JOHN AND BIRTHE MEYER FOUNDATION (2022) to H.K.J., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Ciprofloxacin resistance rapidly declines in nfxB defective clinical strains of Pseudomonas aeruginosa

  • Hernando-Amado, Sara
  • Laborda, Pablo
  • La Rosa, Ruggero
  • Molin, Søren
  • Johansen, Helle Krogh
  • Martínez Menéndez, José Luis
Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41467-025-60330-2, Antibiotic-resistant bacteria could be tackled by identifying trade-offs of evolution, such as high fitness costs, which may be harnessed to force reversion to susceptibility. A decline in antimicrobial resistance can occur through compensatory mutations or by genetic reversion to the wild-type allele, which reduce fitness costs associated with resistance. We analyse here the impact of antibiotic-free environments on declining ciprofloxacin resistance in eight nfxB defective clinical strains of Pseudomonas aeruginosa spanning varied clone types and ciprofloxacin resistance levels. Ciprofloxacin resistance declines in just 100 generations, which is mainly caused by newly acquired mutations in the genes encoding the overproduced efflux pump MexCD-OprJ and not by the reversion of nfxB mutations of the parental strains. The rapid reversion of ciprofloxacin resistance in P. aeruginosa suggests the potential for reusing this essential antibiotic and underlines the need to implement evolution-based approaches against nfxB defective resistant mutant strains., Work was supported by MICIU/AEI/10.13039/501100011033 and FEDER (UE), grant PID2023-149913OA-I00 to SHA and by a Novo Nordisk Foundation (NNF) Challenge grant NNF19OC0056411 to HKJ. PL is the recipient of an ERS/EU RESPIRE4 Marie Skłodowska-Curie Postdoctoral Research Fel- lowship (Ref. nr: R4202305-01047; this project has received funding from the European Respiratory Society and the European Union’s H2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 847462). The Novo Nordisk Foundation is also acknowledged for supporting the NNF Center for Biosustainability (NNF18OC0052776) and the MICIU/AEI/ 10.13039/501100011033 is also acknowledged for supporting the National Center for Biotechnology through the “Severo Ochoa” grant CEX2023-001386-S., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Diagnostic performance of comprehensive point-of-Care ultrasound for pediatric tuberculosis in Spain: A prospective observational study

  • Munyangaju, Isabelle
  • Noguera Julian, Antoni
  • Soler-García, Aleix
  • Soriano-Arandes, Antoni
  • Escudero Fernández, José Miguel
  • Espiau, María
  • Santiago Garcia, Begoña
  • Hernanz-Lobo, Alicia
  • Lancharro Zapata, Ángel M.
  • Ladera, Enrique
  • Manzanares, Angela
  • Blazquez, Daniel
  • Aguirre Pascual, Elisa
  • Thierry-Chef, Isabelle
  • Buonsenso, Danilo
  • Serres-Créixams, Xavier
  • Bassat, Quique
  • Lopez-Varela, Elisa
Background: Diagnosing tuberculosis (TB) in children is challenging because of nonspecific symptoms, low microbiological yield, and imaging limitations. Comprehensive point-of-care ultrasound (cPOCUS) may detect mediastinal lymphadenopathy, but evidence remains limited. Methods: We conducted a prospective observational study in four tertiary hospitals in Spain (May 2023-June 2024) enrolling children (0-18 years) with presumptive TB. All participants underwent chest X-ray (CXR) and cPOCUS; chest CT was performed when clinically indicated. cPOCUS assessed lung, mediastinal, and abdominal compartments using a standardized protocol. Images were independently reviewed by expert readers blinded to clinical data. Diagnostic performance was evaluated against a final TB classification based on clinical, immunological, microbiological, and conventional radiological findings, excluding cPOCUS. Results: Twenty-seven children were included (median age 9.0 years), of whom 12 (44.4%) had TB disease. CT was performed in 14 (51.9%). Only 22.2% of cPOCUS examinations were complete. Mediastinal lymphadenopathy was the most frequent abnormality. cPOCUS detected abnormalities in 58.3%-63.6% of TB cases, particularly aortopulmonary window lymph nodes and small subpleural consolidations, with moderate sensitivity and high specificity (80.0%-86.7%). Inter-reader agreement was high (¿ = 0.92). Conclusions: In this pilot prospective study, cPOCUS demonstrated limited diagnostic performance but high inter-reader reliability. These exploratory findings suggest that cPOCUS may complement standard imaging for selected abnormalities (particularly aortopulmonary window lymphadenopathy), but larger studies with optimized protocols are needed before broader clinical implementation., I.M., Q.B., E.L.-V., and I.T.-C. acknowledge the support from the grant CEX2018-000806-S funded by MCIN/AEI (Ministerio de Ciencia e Innovación)/10.13039/501100011033. I.M. acknowledges the support of a fellowship from the `La Caixa¿ Foundation (ID 100010434). The fellowship code is LCF/BQ/DI21/11860045. E.L.-V. acknowledges the support from European Respiratory Society and the European Union's H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 847462 and Beca de Investigación INVEST-AEP 2022. Grants to A.N.-J.: Carlos III Institute of Health, Ministry of Economy and Competitiveness of Spain (grant no. PI22/00766); and Spanish Society of Pneumology and Thoracic Surgery (grant no. 169-2022). None of the funding sources had a role in the study's design, conduct and reporting. All other authors received no specific funding for this work. There was no additional external funding received for this study.